Cargando…
Prevalence and risk factors of trimethoprim/sulfamethoxazole-related acute kidney injury in pediatric patients: an observational study from a public database
BACKGROUND: Trimethoprim/sulfamethoxazole (TMP/SMZ) is widely used in various clinical settings. Studies have revealed that it may cause acute kidney injury (AKI) in adults. However, the correlation between the use of TMP/SMZ and renal injury in pediatric patients is still unclear. This study aimed...
Autores principales: | Ju, Mohan, Zheng, Mengzhi, Yuan, Jinyi, Lin, Dongfang, Qian, Yiyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442208/ https://www.ncbi.nlm.nih.gov/pubmed/36072532 http://dx.doi.org/10.21037/tp-21-600 |
Ejemplares similares
-
Sulfamethoxazole-Trimethoprim and Hyperkalemia in an Infant
por: Hudzik, Samantha A., et al.
Publicado: (2020) -
Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei
por: Dance, D.A.B., et al.
Publicado: (2014) -
Methemoglobinemia in a Pediatric Oncology Patient Receiving Sulfamethoxazole/Trimethoprim Prophylaxis
por: Carroll, Timothy G., et al.
Publicado: (2016) -
Trimethoprim/sulfamethoxazole‐induced methemoglobinemia in pediatric patient: A case report
por: Alotaibi, Sultan, et al.
Publicado: (2023) -
Myocarditis after Trimethoprim/Sulfamethoxazole Treatment for Ehrlichiosis
por: Nayak, Seema U., et al.
Publicado: (2013)